Shenzhen Bao'an District Songgang People's Hospital, Shenzhen 518100, China.
School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
Biomed Res Int. 2020 Dec 22;2020:7020924. doi: 10.1155/2020/7020924. eCollection 2020.
Renal cell carcinoma (RCC) is one of the ten most common cancers in the globe. Despite the diagnosis and treatment of renal cell carcinoma that have made great improvements, the morbidity and mortality rates of renal cell carcinoma remain unchanged remarkably. LHPP is a kind of histidine phosphatases, acting as a tumor suppressor in the progression of various cancers. In this study, we found that LHPP was significantly downregulated in RCC tissues and cell lines. Decreased expression of LHPP was closely correlated with tumor size and postoperative metastasis of RCC patients. In addition, overexpression of LHPP inhibited the proliferation and metastasis of RCC. However, suppression of LHPP promoted the proliferation and metastasis of RCC. In conclusion, our results presented the important role of LHPP in the development and progression of RCC.
肾细胞癌(RCC)是全球十大最常见癌症之一。尽管在肾细胞癌的诊断和治疗方面取得了很大的进展,但肾细胞癌的发病率和死亡率仍然显著不变。LHPP 是一种组氨酸磷酸酶,在各种癌症的进展中起肿瘤抑制作用。在这项研究中,我们发现 LHPP 在 RCC 组织和细胞系中显著下调。LHPP 的表达降低与 RCC 患者的肿瘤大小和术后转移密切相关。此外,LHPP 的过表达抑制了 RCC 的增殖和转移。然而,抑制 LHPP 促进了 RCC 的增殖和转移。总之,我们的结果表明 LHPP 在 RCC 的发展和进展中起着重要作用。